Page last updated: 2024-08-24

repaglinide and Chronic Disease

repaglinide has been researched along with Chronic Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abernethy, DR; Arya, V; Atkinson, AJ; Berglund, EG; Grillo, JA; Huang, SM; Lesko, LJ; Pang, KS; Reynolds, KS; Song, P; Sugiyama, Y; Vieira, Mde L; Wu, TC; Zhang, L; Zhao, P; Zheng, JH1
Christensen, MS; Hatorp, V; Haug-Pihale, G; Walther, KH1

Trials

1 trial(s) available for repaglinide and Chronic Disease

ArticleYear
Single-dose pharmacokinetics of repaglinide in subjects with chronic liver disease.
    Journal of clinical pharmacology, 2000, Volume: 40, Issue:2

    Topics: Adult; Blood Glucose; Blood Proteins; Caffeine; Carbamates; Chronic Disease; Humans; Hypoglycemic Agents; Liver Diseases; Male; Middle Aged; Piperidines; Protein Binding

2000

Other Studies

1 other study(ies) available for repaglinide and Chronic Disease

ArticleYear
Evaluation of exposure change of nonrenally eliminated drugs in patients with chronic kidney disease using physiologically based pharmacokinetic modeling and simulation.
    Journal of clinical pharmacology, 2012, Volume: 52, Issue:1 Suppl

    Topics: Area Under Curve; Carbamates; Chronic Disease; Computer Simulation; Drug Interactions; Humans; Ketolides; Kidney Diseases; Models, Biological; Piperazines; Piperidines; Purines; Sildenafil Citrate; Sulfones

2012